Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing-Reference-Cited by-同舟云学术

Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing

Published:2020-12-26 Issue:9 Volume:73 Page:e3098-e3101
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Pilarowski Genay¹,Marquez Carina²,Rubio Luis²,Peng James²,Martinez Jackie²,Black Douglas²,Chamie Gabriel²,Jones Diane³,Jacobo Jon³,Tulier-Laiwa Valerie³,Rojas Susana³,Rojas Susy³,Cox Chesa²,Nakamura Robert⁴,Petersen Maya⁵,DeRisi Joseph⁶⁷,Havlir Diane V²

Affiliation:

1. Department of Pathology, Stanford University, Palo Alto, California, USA

2. Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, USA

3. Unidos en Salud/United in Health, San Francisco, California, USA

4. California Department of Public Health, Microbial Diseases Laboratory, Richmond, California, USA

5. Division of Epidemiology and Biostatistics, University of California, Berkeley, California, USA

6. Department of Biochemistry and Biophysics, University of California San Francisco, CA, USA

7. Chan Zuckerberg Biohub, San Francisco, California, USA

Abstract

Abstract Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by BinaxNOWTM and reverse transcription polymerase chain reaction (RT-PCR) in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR cycle thresholds of 30, 35, and no threshold. The specificity was 99.9%. Performance was high across ages and those with and without symptoms. Rapid resulting permitted immediate public health action.

Funder

National Institutes of Health

Sandler Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1890/36781286/ciaa1890.pdf

Reference12 articles.

1. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review;Oran;Ann Intern Med,2020

2. SARS-CoV-2 community transmission disproportionately affects Latinx population during shelter-in-place in San Francisco;Chamie;Clin Infect Dis,2020

3. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening;Larremore;Sci Adv,2020

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Accuracy of the Abbot BinaxNOW COVID-19 Antigen Card Test, Puerto Rico;2023-12-15

2. The New Normal: Delayed Peak Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Loads Relative to Symptom Onset and Implications for Coronavirus Disease 2019 (COVID-19) Testing Programs;Clinical Infectious Diseases;2023-09-28

3. Assessment of the detection accuracy of SARS-CoV-2 rapid antigen test in children and adolescents: An updated meta-analysis;Journal of the Chinese Medical Association;2023-09-08

4. Daily SARS-CoV-2 Nasal Antigen Tests Miss Infected and Presumably Infectious People Due to Viral Load Differences among Specimen Types;Microbiology Spectrum;2023-08-17

5. Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2;Bioengineered;2023-07-25